Risk group allocation applied by the GHSG
| Risk group . | Stage . |
|---|---|
| Early stages | Stage I/II with no risk factors |
| Intermediate stages | Stage I/IIA with ≥1 risk factor(s) |
| Stage IIB with risk factors C/D, but not A/B | |
| Advanced stages | Stage IIB with risk factors A/B |
| Stage III/IV | |
| Risk factors | (A) Large mediastinal mass* |
| (B) Extranodal disease | |
| (C) Elevated ESR† | |
| (D) ≥3 nodal areas |
| Risk group . | Stage . |
|---|---|
| Early stages | Stage I/II with no risk factors |
| Intermediate stages | Stage I/IIA with ≥1 risk factor(s) |
| Stage IIB with risk factors C/D, but not A/B | |
| Advanced stages | Stage IIB with risk factors A/B |
| Stage III/IV | |
| Risk factors | (A) Large mediastinal mass* |
| (B) Extranodal disease | |
| (C) Elevated ESR† | |
| (D) ≥3 nodal areas |